Otsuka Holdings Co Ltd (4578) - Financial and Strategic SWOT Analysis Review

Otsuka Holdings Co Ltd (4578) - Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH219028FSA
  • |
  • Pages: 60
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Otsuka Holdings Co Ltd (4578)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Otsuka Holdings Co Ltd (Otsuka) is a holding company, which operates various businesses such as pharmaceuticals, nutraceuticals, consumer products and other businesses through its subsidiaries. It focuses on the research and development, manufacture, and sale of medicines for the treatment of cancer, cardiovascular diseases, central nervous system disorders, ophthalmic diseases, gastrointestinal and respiratory diseases, infectious diseases, dermatological conditions and allergies. The company's product portfolio includes pharmaceutical products, cosmetics, functional foods and beverages, alcoholic beverages, fine chemicals, electronic equipment, functional chemicals, medical devices and OTC products. It markets its products in North America, Europe and Asia. Otsuka is headquartered in Chiyoda-ku, Tokyo, Japan.

Otsuka Holdings Co Ltd Key Recent Developments

Oct 15,2018: Otsuka and Proteus Digital Health Announce Expanded Collaboration Agreement to Advanced Digital Medicines for Mental Health

Oct 15,2018: Otsuka expands digital medicines alliance with Proteus Digital

Aug 08,2018: Otsuka Holdings reports consolidated financial results for the second quarter of the fiscal year ending December 31, 2018

Jul 11,2018: Otsuka Medical Devices to merge with ReCor Medical

Mar 29,2018: Otsuka Holdings appoints board members and audit & supervisory board members

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Otsuka Holdings Co Ltd-Key Facts 6

Otsuka Holdings Co Ltd-Key Employees 7

Otsuka Holdings Co Ltd-Major Products and Services 8

Otsuka Holdings Co Ltd-History 11

Otsuka Holdings Co Ltd-Company Statement 16

Otsuka Holdings Co Ltd-Locations And Subsidiaries 17

Head Office 17

Other Locations & Subsidiaries 17

Section 2-Company Analysis 20

Company Overview 20

Otsuka Holdings Co Ltd-Business Description 21

Business Segment: Consumer Product Business 21

Overview 21

Performance 21

Business Segment: Nutraceutical Business 21

Overview 21

Performance 21

Business Segment: Other Businesses 22

Overview 22

Performance 22

Business Segment: Pharmaceutical Business 22

Overview 22

Performance 22

R&D Overview 22

Otsuka Holdings Co Ltd-Corporate Strategy 24

Otsuka Holdings Co Ltd-SWOT Analysis 25

SWOT Analysis-Overview 25

Otsuka Holdings Co Ltd-Strengths 25

Otsuka Holdings Co Ltd-Weaknesses 26

Otsuka Holdings Co Ltd-Opportunities 27

Otsuka Holdings Co Ltd-Threats 28

Otsuka Holdings Co Ltd-Key Competitors 29

Section 3-Company Financial Ratios 30

Financial Ratios-Capital Market Ratios 30

Financial Ratios-Annual Ratios 31

Performance Chart 34

Financial Performance 34

Financial Ratios-Interim Ratios 35

Financial Ratios-Ratio Charts 36

Section 4-Company's Lifesciences Financial Deals and Alliances 37

Otsuka Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 37

Otsuka Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 38

Otsuka Holdings Co Ltd, Recent Deals Summary 39

Section 5-Company's Recent Developments 40

Oct 15, 2018: Otsuka and Proteus Digital Health Announce Expanded Collaboration Agreement to Advanced Digital Medicines for Mental Health 40

Oct 15, 2018: Otsuka and Proteus Digital Health Announce Expanded Collaboration Agreement to Advanced Digital Medicines for Mental Health 41

Oct 15, 2018: Otsuka and Proteus Digital Health Announce Expanded Collaboration Agreement to Advanced Digital Medicines for Mental Health 42

Oct 15, 2018: Otsuka and Proteus Digital Health Announce Expanded Collaboration Agreement to Advanced Digital Medicines for Mental Health 43

Oct 15, 2018: Otsuka and Proteus Digital Health Announce Expanded Collaboration Agreement to Advanced Digital Medicines for Mental Health 44

Oct 15, 2018: Otsuka expands digital medicines alliance with Proteus Digital 45

Oct 15, 2018: Otsuka expands digital medicines alliance with Proteus Digital 46

Oct 15, 2018: Otsuka expands digital medicines alliance with Proteus Digital 47

Aug 08, 2018: Otsuka Holdings reports consolidated financial results for the second quarter of the fiscal year ending December 31, 2018 48

Jul 11, 2018: Otsuka Medical Devices to merge with ReCor Medical 55

Section 6-Appendix 56

Methodology 56

Ratio Definitions 56

About GlobalData 60

Contact Us 60

Disclaimer 60

List of Figures

Otsuka Holdings Co Ltd, Performance Chart (2013-2017) 34

Otsuka Holdings Co Ltd, Ratio Charts 36

Otsuka Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 37

Otsuka Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 38

List of Tables

Otsuka Holdings Co Ltd, Key Facts 6

Otsuka Holdings Co Ltd, Key Employees 7

Otsuka Holdings Co Ltd, Major Products and Services 8

Otsuka Holdings Co Ltd, History 11

Otsuka Holdings Co Ltd, Subsidiaries 17

Otsuka Holdings Co Ltd, Key Competitors 29

Otsuka Holdings Co Ltd, Ratios based on current share price 30

Otsuka Holdings Co Ltd, Annual Ratios 31

Otsuka Holdings Co Ltd, Annual Ratios (Cont...1) 32

Otsuka Holdings Co Ltd, Annual Ratios (Cont...2) 33

Otsuka Holdings Co Ltd, Interim Ratios 35

Otsuka Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 37

Otsuka Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 38

Otsuka Holdings Co Ltd, Recent Deals Summary 39

Currency Codes 56

Capital Market Ratios 56

Equity Ratios 57

Profitability Ratios 57

Cost Ratios 58

Liquidity Ratios 58

Leverage Ratios 59

Efficiency Ratios 59

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Taisho Pharmaceutical Holdings Co Ltd

Rohto Pharmaceutical Co Ltd

Mitsubishi Tanabe Pharma Corp

Daiichi Sankyo Co Ltd

Chugai Pharmaceutical Co Ltd

Astellas Pharma Inc

Otsuka Holdings Co Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license
Single User License
USD 125 INR 8873
Site License
USD 250 INR 17745
Corporate User License
USD 375 INR 26618

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com